Holen Sie sich die Stockscreener-App
6.54
0.15%
0.010
Handel nachbörslich:
6.54
Schlusskurs vom Vortag:
$6.53
Offen:
$6.5
24-Stunden-Volumen:
155.30K
Relative Volume:
0.47
Marktkapitalisierung:
$177.07M
Einnahmen:
$348.67M
Nettoeinkommen (Verlust:
$-22.75M
KGV:
-7.1366
EPS:
-0.9164
Netto-Cashflow:
$-21.60M
1W Leistung:
-0.91%
1M Leistung:
-0.76%
6M Leistung:
-6.97%
1J Leistung:
-10.53%
1-Tages-Spanne:
$6.40
$6.57
1-Wochen-Bereich:
$6.29
$6.78
52-Wochen-Spanne:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.54 | 177.07M | 348.67M | -22.75M | -21.60M | -0.9164 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Inogen (INGN) Stifel 2024 Healthcare Conference Summary - Quartr
Form 4 Inogen Inc For: 9 July By Investing.com - Investing.com Nigeria
Inogen (INGN) EVP, COO awarded 130,000 restricted stock units vesting from 2026 - Stock Titan
Inogen (INGN) EVP, COO Andrew Reding files baseline Form 3 insider report - Stock Titan
Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inogen Inc (INGN) executive sells 10,938 shares in planned trade - Stock Titan
Inogen Inc (INGN) Slips Slightly Amidst Range-Bound TradingPrice Surge Stocks - dars.gov.et
INGNInogen Inc Volatility & Greeks - Finviz
Inogen Appoints New Chief Operating Officer for Growth - The Globe and Mail
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer - BioSpace
Inogen appoints Andy Reding as chief operating officer - Investing.com
[144] Inogen Inc SEC Filing - Stock Titan
Inogen (INGN) Appoints New COO to Enhance Operational Efficiency - GuruFocus
Inogen Appoints Reding to New COO Role - Moomoo
Inogen (Nasdaq: INGN) adds COO Andy Reding with equity package - Stock Titan
Inogen, Inc. Financial Disclosures & Filings - TradingView
Inogen Inc (INGN) Q1 2026 Earnings: EPS Miss Weighs on Shares as Revenue Details Remain DisclosedEarnings Surprise Score - dars.gov.et
Tranche Update on Inogen, Inc.'s Equity Buyback Plan announced on February 24, 2026. - marketscreener.com
Here's why you should retain Inogen stock in your portfolio for now - MSN
Inogen, Inc. Actuals & Estimates (NASDAQ:INGN) - TradingView
Inogen, Inc. Actuals & Estimates (LSX:A1XB32) - TradingView
Inogen, Inc. Actuals & Estimates (SWB:6IO) - TradingView
Enterprise value to EBIT forward of Inogen, Inc – NASDAQ:INGN - TradingView
Price to sales forward of Inogen, Inc – NASDAQ:INGN - TradingView
Enterprise value to revenue forward of Inogen, Inc – NASDAQ:INGN - TradingView
Inogen, Inc. Actuals & Estimates (GETTEX:6IO) - TradingView
INGN Forecast — Price Target — Prediction for 2027 - TradingView
6IO Forecast — Price Target — Prediction for 2027 - TradingView
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Zacks Investment Research
Precision Trading with Inogen Inc (INGN) Risk Zones - Stock Traders Daily
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
INGN Q1 2026 Earnings: EPS Misses Estimates as Revenue Details UnavailableProfit Inflection Point - dars.gov.et
Inogen Inc Stock (US45780L1044): Valuation metrics under the microscope - AD HOC NEWS
INGN SEC FilingsInogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Former ZimVie CEO Joins Inogen’s Board of Directors - Medical Product Outsourcing
Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan and Stock Option Agreement Details 57 - Minichart
Inogen Shareholders Approve Expanded Equity Incentive Plan - TipRanks
Inogen (NASDAQ: INGN) holders back equity plan but keep staggered board - Stock Titan
Inogen (INGN) director awarded 28,081 RSUs, boosting share holdings - Stock Titan
Inogen (INGN) director Jamali Vafa receives 28,081-share RSU grant - Stock Titan
Inogen Inc (INGN) awards director Glenn Boehnlein 28,081 stock units - Stock Titan
Inogen (NASDAQ: INGN) director granted 28,081 restricted stock units in equity award - Stock Titan
Inogen (NASDAQ: INGN) director awarded 28,081 restricted stock units - Stock Titan
Inogen (INGN) director receives 28,081-share restricted stock unit grant - Stock Titan
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):